JPRN-UMIN000039372已完成未知
Validation study of time-dependent change of blood glucose level after taking yeast-containing foods. - Validation study of time-dependent change of blood glucose level after taking yeast-containing foods.
imeQ RD inc.0 个研究点目标入组 10 人开始时间: 2020年2月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Those who are currently receiving some types of drug (except for the drugs that are taken as needed). 2. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3. Those who have or had a severe disease of the liver, kidneys, endocrine, heart ,gastrointestinal tract, respiratory system, blood, and metabolism. 4. Those who underwent gastrointestinal surgery. 5. Those who are currently taking the following products which affect glucose blood level: pharmaceutical products, health foods, or supplements. 6. Those who have a past and current medical history of drug or food allergy. 7. Those who may have allergic reactions to test food. 8. Those who work night shifts. 9. Smokers. 10. Heavy drinkers. 11. Those who are currently participating in another clinical trial or who had participated in another clinical trial conducted within a month prior to the submission of an informed consent document. 12. Those who experienced a feeling of being unwell or deterioration of health condition when they had blood drawn.
研究者
相似试验
已完成
不适用
Changes of flow in Arterial anastomosis of Free flap after the Intraoperative administration of AlprostadilDiseases of the skin and subcutaneous tissueKCT0002166Asan Medical Center44
进行中（未招募）
不适用
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary arterial hypertensionEUCTR2010-018863-40-DEBayer HealthCare AG18
进行中（未招募）
不适用
An interaction study to evaluate changes in blood pressure following 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) compared to placebo treatment on the background of stable sildenafil pretreatment in subjects with symptomatic pulmonary arterial hypertension - PATENT PLUSPulmonary arterial hypertension.MedDRA version: 9.1Level: LLTClassification code 10064911EUCTR2010-018863-40-ITBayer Health Care AG36
进行中（未招募）
不适用
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersPulmonary arterial hypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-018863-40-CZBayer HealthCare AG36
进行中（未招募）
不适用
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersMedDRA version: 14.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary arterial hypertensionEUCTR2010-018863-40-PLBayer HealthCare AG36